Jubilant Cadista Pharmaceuticals, Inc. recalls Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals,
Jubilant Cadista recalls 4mg methylprednisolone tablets with misaligned dosing instructions on blister cards. Consumers should check NDC 59746-001-03 and specific lot numbers for affected products.
Lower-risk recall
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista is recalling 4mg methylprednisolone tablets due to illegible dosing instructions on the blister card. This could lead to incorrect dosing if the label is not readable. Read more at govinfonow.com/recall/36501-jubilant-cadista-methylprednisolone-tablets-illegible-dosing-instructions-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/36501-jubilant-cadista-methylprednisolone-tablets-illegible-dosing-instructions-recall · Updated October 4, 2026 · FDA enforcement record: FDA #D-0298-2021
Cite this page
“Jubilant Cadista Methylprednisolone Tablets: Illegible Dosing Instructions Recall.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36501-jubilant-cadista-methylprednisolone-tablets-illegible-dosing-instructions-recall. Based on FDA recall #D-0298-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0298-2021%22&limit=1).
Why it’s dangerous
The dosing instructions on the blister card are misaligned, making them difficult to read. This could lead to incorrect dosing if the label is not clear. However, the product is still safe for use when the label is readable.
Who’s affected
Prescription patients who received the recalled 4mg methylprednisolone tablets with misaligned dosing instructions on the blister card. Those using the product without proper label readability are at slightly higher risk.
How to tell if you have this one
Check for NDC 59746-001-03 and lot numbers 20K0042P-20K0044P (expiring 08/2022) or 20L0026P-20L0030P (expiring 09/2022). The product is prescription-only and packaged in a 21-count blister pack.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Check Label Readability
Inspect the blister card for misaligned dosing instructions that are difficult to read.
Questions people ask
Is this product safe to use?
Yes, the product is safe for use if the dosing instructions are readable. The recall is due to potential misalignment, not safety issues.
What lot numbers are affected?
Lot numbers 20K0042P-20K0044P (expiring 08/2022) and 20L0026P-20L0030P (expiring 09/2022).
How can I confirm if I have the recalled product?
Check the NDC code 59746-001-03 and the specific lot numbers listed in the recall notice.
Contact Jubilant Cadista
We’ve drafted a message you can send Jubilant Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-0298-2021 — Jubilant Cadista Jubilant Cadista Hello, I own a Jubilant Cadista that is covered by recall D-0298-2021 from Jubilant Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0298-2021 (February 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0298-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.